CYTO
Altamira Therapeutics Ltd
CYTO
CYTO
Delisted
CYTO was delisted on the 19th of December, 2024.
11 hedge funds and large institutions have $1.77M invested in Altamira Therapeutics Ltd in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
11
Holding in Top 10
–
Calls
$250K
Puts
$289K
Top Buyers
| 1 | +$68.2K | |
| 2 | +$36K | |
| 3 | +$14.3K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.75K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5K |
Top Sellers
| 1 | -$204K | |
| 2 | -$180K | |
| 3 | -$159K | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$69K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$44K |